Get Your Personalized Supplement StackSupplement Stack Quiz

Peony

Also known as: Total glucosides of peony, TGP, Peony glucosides, Paeony total glucosides, Paeonia lactiflora

Overview

Total glucosides of peony (TGP) is an herbal extract derived from the roots of *Paeonia lactiflora* Pall., a plant prominent in traditional Chinese medicine. Widely recognized for its anti-inflammatory, immunomodulatory, and antioxidant properties, TGP is utilized primarily for managing autoimmune and inflammatory conditions such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and chronic urticaria (CU). As research surrounding TGP evolves, recent systematic reviews and meta-analyses indicate moderate to high quality evidence supporting its efficacy. Despite some methodological limitations across studies, TGP's potential to enhance standard treatment regimens renders it a significant focus of contemporary health research.

Benefits

The key benefits of TGP include notable improvements in clinical outcomes for autoimmune diseases. For instance, in rheumatoid arthritis, TGP combined with methotrexate demonstrates significant reductions in erythrocyte sedimentation rate (ESR) and swollen joint count (SJC), highlighting its effectiveness compared to methotrexate alone. In systemic lupus erythematosus, TGP aids in enhancing therapeutic effects, though specific improvements are less clear and warrant further exploration. Chronic urticaria patients also report a decrease in symptom severity when TGP serves as an adjunctive treatment. Importantly, TGP appears to correlate with a reduction in adverse events compared to monotherapy with standard treatments, promoting its safety profile within clinical contexts.

How it works

TGP exhibits its effects through several biological pathways, specifically by modulating inflammatory and immune responses. It alters cytokine levels, thereby reducing inflammation and oxidative stress within the body. While the precise molecular mechanisms remain to be fully delineated, TGP is believed to act on various inflammatory mediators, enhancing the body's immune modulation. Although absorption and bioavailability studies are sparse, its clinical effectiveness suggests adequate bioavailability in therapeutic contexts.

Side effects

TGP is regarded as safe for use alongside standard therapies; however, comprehensive long-term safety data remains limited. Common side effects specifically tied to TGP are not well-documented, but combinations with other therapies generally result in fewer adverse events compared to monotherapy. Uncommon and rare side effects are not reported within systematic reviews. Potential interactions with immunosuppressive and anti-inflammatory medications exist, but their nature requires further research for elucidation. Caution is recommended for patients with significant kidney or liver disorders due to insufficient data on TGP's safety in such cases. Moreover, pregnant or breastfeeding individuals should use TGP judiciously owing to a lack of safety information.

Dosage

The effective dosage of TGP can vary based on the specific condition being treated; for rheumatoid arthritis, clinical studies often employ doses ranging from 500 mg to 1000 mg per day. While maximum safe doses have not been firmly established, the use of up to 1000 mg daily has shown no significant adverse effects in trials. TGP is typically administered orally, generally in capsule or tablet form, without specified timing for consumption. The formulation's absorption is anticipated to be adequate, although the factors affecting this have not been comprehensively studied, and no essential cofactors for efficacy have been identified.

FAQs

Is TGP safe to use?

TGP is generally safe when combined with conventional therapies; however, long-term safety and potential drug interactions need further research.

What is the dosage of TGP?

Doses for rheumatoid arthritis usually range from 500 mg to 1000 mg daily, depending on the specific condition and combination with other treatments.

What results can I expect from TGP?

Patients may see improved clinical outcomes for autoimmune diseases like RA and SLE when combining TGP with standard treatments.

Can TGP replace my current medications?

TGP should not replace conventional therapies but can serve as an adjunctive treatment to improve efficacy and minimize side effects.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/28748514/ – This study presented a systematic review and meta-analysis indicating that TGP, when used in conjunction with methotrexate, significantly improves therapeutic outcomes for rheumatoid arthritis compared to methotrexate alone, evidenced by marked reductions in ESR and SJC.
https://gpsych.bmj.com/content/31/1/e100003 – This meta-analysis explored the efficacy of TGP alongside conventional therapies for systemic lupus erythematosus, finding that while TGP enhances clinical outcomes, the specifics of its effects require further high-quality studies for clarification.
https://pubmed.ncbi.nlm.nih.gov/32718360/ – This systematic review evaluated the role of TGP in chronic urticaria, indicating that as an adjunctive treatment, it significantly reduces the severity of symptoms, although further studies are necessary for understanding long-term effects.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.932874/full – This comprehensive review highlights the role of TGP in various inflammatory conditions, underlining its immunomodulatory properties and potential benefits in autoimmune disease management.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.961371/full – This review focuses on TGP’s multiple therapeutic applications and effects, primarily emphasizing its synergistic role with conventional treatments in managing autoimmune disorders.